Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1101/032144 | Wikidata as a semantic framework for the Gene Wiki initiative |
| https://doi.org/10.1111/j.1423-0410.2006.00832.x | Use of a (proposed) standard protocol to validate Terumo TSCD‐II connections between dissimilar blood bag tubing |
| https://doi.org/10.1101/799684 | Wikidata as a FAIR knowledge graph for the life sciences |
| https://doi.org/10.12697/akut.2008.13s.01 | Abstracts of the First Baltic Conference in Exercise and Sports Sciences and the First Baltic Conference of Young Scientists in Exercise and Sports Sciences, 7–10 May 2008, Tartu, Estonia |
| Measures to encourage professional competence. | |
| https://doi.org/10.1016/j.jval.2018.04.1201 | The Burden of Sickle Cell Disease |
| https://doi.org/10.1016/j.jval.2018.09.1508 | PMD59 - DEVELOPING A COMPREHENSIVE TREATMENT COST COMPARISON MODEL IN SICKLE CELL DISEASE |
| https://doi.org/10.1016/j.jval.2018.09.1509 | PMD60 - DEVELOPING A COMPREHENSIVE TREATMENT COST COMPARISON MODEL IN GUILLAIN-BARRE SYNDROME AND MYASTHENIA GRAVIS TO COMPARE THE TOTAL COST OF IVIG BASED TREATMENT VERSUS CENTRIFUGAL THERAPEUTIC PLASMA EXCHANGE |
| https://doi.org/10.1016/j.jval.2018.09.1968 | PND1 - REVIEW OF THE LISTED SIDE EFFECTS OF MYASTHENIA GRAVIS TREATMENTS VERSUS THOSE RECORDED IN PUBLICATIONS |
| https://doi.org/10.1016/j.jval.2018.09.1972 | PND5 - A LITERATURE REVIEW REPORTING THE SIDE EFFECTS AND ANY RELATED CONSEQUENCES CAUSED BY CURRENT CHRONIC MYASTHENIA GRAVIS TREATMENTS |
| https://doi.org/10.1016/j.jval.2019.04.1036 | PMD39 MEASURING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SICKLE CELL DISEASE UNDERGOING AUTOMATED RED BLOOD CELL EXCHANGE |
| https://doi.org/10.1016/j.jval.2019.04.1035 | PMD38 MUTUAL UNDERSTANDING BETWEEN SICKLE CELL DISEASE PATIENTS THAT REQUIRE BLOOD TRANSFUSION AND THEIR TREATING PHYSICIANS CONCERNING DRIVERS OF QUALITY OF LIFE |
| https://doi.org/10.1016/j.vhri.2019.08.269 | PMD1 PATIENT OUTCOMES IN CENTRIFUGE AND MEMBRANE THERAPEUTIC PLASMA EXCHANGE (TPE): LITERATURE REVIEW WITH A FOCUS ON THE CHILEAN & COLOMBIAN MARKETS |
| https://doi.org/10.1016/j.vhri.2019.08.274 | PMD6 CENTRIFUGAL VERSUS MEMBRANE THERAPEUTIC PLASMA EXCHANGE: A CHILEAN, MULTI-CENTER, COST-COMPARISON STUDY |
| https://doi.org/10.1016/j.vhri.2019.08.277 | PMD10 ESTUDIO MULTICÉNTRICO DE COSTOS DEL RECAMBIO PLASMÁTICO TERAPÉUTICO (RPT) CON LOS SISTEMAS DE FILTRACIÓN TRANSMEMBRANA Y DE CENTRIFUGACIÓN EN COLOMBIA |
| https://doi.org/10.1016/j.vhri.2019.08.412 | PRO4 COST-EFFECTIVENESS ANALYSIS OF AN INTEGRATED EXTRACORPOREAL PHOTOPHERESIS SYSTEM VERSUS SELECTED TREATMENTS FOR REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE |
| https://doi.org/10.1016/j.jval.2019.09.1429 | PMD16 HEALTH ECONOMIC VALUE OF BLOOD IN IVORY COAST: THE CASE OF MATERNAL BLEEDING |
| https://doi.org/10.1016/j.jval.2019.09.1964 | PNS62 HEALTH ECONOMIC VALUE OF BLOOD IN GHANA: THE CASE OF MATERNAL BLEEDING |
| https://doi.org/10.1016/j.jval.2019.09.2084 | PNS184 THE VALUE OF BLOOD IN SUB-SAHARAN AFRICA |
| https://doi.org/10.1016/j.jval.2019.09.2059 | PNS158 HEALTH ECONOMIC VALUE OF BLOOD IN SUB-SAHARAN AFRICA: THE CASE OF MATERNAL BLEEDING |
| https://doi.org/10.1016/j.jval.2020.04.572 | PMD2 HEALTH OUTCOMES ASSOCIATED WITH DIFFERENT TRANSFUSION MODALITIES IN SICKLE CELL DISEASE |
| https://doi.org/10.1016/j.jval.2020.08.1040 | PMD7 A Stakeholder Perspective on the Health Economic Cost of Sickle Cell Disease in Function of Preferred Transfusion Modality |
| https://doi.org/10.1016/j.jval.2020.08.1046 | PMD13 A Health Economic Evaluation of the Impact of Pathogen Reduction Technology on Emerging Pathogens within the Platelet Collection and Transfusion Space |
| https://doi.org/10.1016/j.jval.2020.08.1044 | PMD11 Can Blood Units Coming from Whole Blood Automation Deliver a Clinically Meaningful Difference to Anemic Patients Versus Alternative Blood Collection Types? |
| https://doi.org/10.1016/j.jval.2020.08.1778 | PRO42 Cost Comparison Analysis of Transfusion Modalities for Patients Suffering from Sickle Cell Disease for the Brazilian National Healthcare System (SUS) |
| https://doi.org/10.1016/j.jval.2020.08.1063 | PMD30 Literature Review on Whole Blood Automation Using Automated Blood Processing System (ABPS) |
| https://doi.org/10.1016/j.jval.2021.11.426 | POSB153 Health Economic Evaluation of Different Treatment Modalities for Extracorporeal Photopheresis: Can New Alternatives Generate Health Economic Value? |
| https://doi.org/10.1016/j.jval.2021.11.555 | POSC153 Long-Term Cost Efficiencies Linked to Automated vs. Manual Fill and Finish Process in Cell and Gene Therapy Manufacturing |
| https://doi.org/10.1016/j.jval.2021.11.946 | POSB297 Assessing the Cost and Value Drivers of Automation in Cell and Gene Therapy Manufacturing: A Decision Guide |
| https://doi.org/10.1007/s00464-007-9593-1 | A possible mechanism of peritoneal pH changes during carbon dioxide pneumoperitoneum |
| https://doi.org/10.1016/j.jval.2019.09.1861 | PND91 APPLICATION OF BIG DATA IN RARE DISEASE MANAGEMENT: TREATMENT COST OF THERAPEUTIC PLASMA EXCHANGE VERSUS IMMUNOGLOBULINS IN AN INPATIENT SETTING |
| https://doi.org/10.1016/j.jval.2022.04.419 | EE170 Implementation of an Evidence-Based, Software Application to Compare Automation Blood Processing Systems (ABPS) Vs. Semi-Automated Blood Processing Systems |
| https://doi.org/10.1016/j.avsg.2022.06.078 | Cost and budgetary impact of the vascular systems of closure versus manual compression for peripheral endovascular procedures |
| https://doi.org/10.1016/j.jval.2023.03.1695 | MT50 Value Stream Mapping and Analysis of the Quality Parameters from the Control Units Processed Using a Semi-Automated, Buffy Coat Method, in a Colombian Blood Bank Center |
| https://doi.org/10.1016/j.jval.2023.03.1664 | MT17 Assessment of the Productivity Features and Analysis of the Quality Parameters from the Control Units Processed Using a Semi-Automated, Buffy Coat Method, in a Colombian Blood Bank Center |
| https://doi.org/10.1016/j.jval.2023.03.700 | EE399 Assessing the Risks and Benefits Associated with Automation during Cell Expansion Processes at Cell and Gene Therapy Manufacturers |
| https://doi.org/10.1162/dint_a_00236 | Building Expertise on FAIR Through Evolving Bring Your Own Data (BYOD) Workshops: Describing the Data, Software, and Management-focused Approaches and Their Evolution |
| https://doi.org/10.1186/s12915-023-01764-2 | Author Correction: A protocol for adding knowledge to Wikidata: aligning resources on human coronaviruses |
| https://doi.org/10.1016/j.jval.2023.09.2539 | PCR100 Vascular Access Adverse Events: A Comprehensive Literature Review and Comparative Analysis |
| https://doi.org/10.1016/j.jval.2023.09.2484 | PCR45 Vascular Access Devices: A Comparative Analysis of Complications and Their Cost Implications |
| https://doi.org/10.1016/j.jval.2023.09.1190 | EPH148 Disease Burden of Sickle Cell Disease in Saudi Arabia |
| https://doi.org/10.1016/j.jval.2024.03.1565 | MT27 Comparison of Quality Parameters from Control Units Processed with Semi-Automated and Automated Processing Systems in the Colombian Blood Bank Hospital Pablo Tobón Uribe |
| https://doi.org/10.1016/j.jval.2024.03.1574 | MT36 Assessment and Comparison of the Manual Steps Required to Perform Whole Blood Processing Using a Semi-Automated Method Versus a Fully Automated Method |
| https://doi.org/10.3389/fphy.2024.1441316 | Automated size-specific dosimetry for chest posterior–anterior projection radiography |
| https://doi.org/10.1111/vox.13752 | An ecosystem of interconnected technologies to increase efficiencies in blood establishments: The example of the Blood and Tissue Bank of Aragón, Spain |
| https://doi.org/10.1182/blood-2024-207813 | Clinical and Economic Impact of Long-Term Disease Modifying Transfusions in Paediatrics As a Prophylactic Intervention for Sickle Cell Disease Crises |
| https://doi.org/10.1182/blood-2024-207402 | Clinical and Economic Impact of Long-Term Disease Modifying Transfusions in Adults As a Prophylactic Intervention for Sickle Cell Disease Crises |
| https://doi.org/10.3390/bioengineering12101109 | Correction: Bräuchle et al. Large-Scale Expansion of Suspension Cells in an Automated Hollow-Fiber Perfusion Bioreactor. Bioengineering 2025, 12, 644 |
| https://doi.org/10.1002/jca.70081 | From Traditional to Crude Collection Efficiency: A Comprehensive Analysis of the Impact of Processed Volume |
| https://doi.org/10.1016/j.jval.2025.09.1015 | EE633 Real-World Cost of Automated Red Blood Cell Exchange for Sickle Cell Disease in Kenya: A Cost-Reimbursement Gap Analysis From a Public Sector Perspective |
| https://doi.org/10.1016/j.jval.2025.09.794 | EE411 Enhancing Operational Efficiency: Time and Cost Savings of a Minimally Invasive Vascular Closure Device in Germany |